In our study of a homogenous cohort of patients with newly diagnosed metastatic EGFR mutation harbouring lung adenocarcinoma treated with EGFR TKI in the 1st line, we found no evidence that smoking status or heavy smoking had a significant impact on PFS and OS, contrary to the recent report by Kim et al [8]. This evidence concerns the gene EGFR and lung adenocarcinoma.